Gene · 4070
Papers3,230
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
401 to 420 of 3,230
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Diagnostic Significance of Trophoblast Cell Surface Antigen-2 Expression in Benign and Malignant Thyroid Lesions. | Cureus | 2025 | 41426858 | PubTator, text mining | PubMed |
| Prognostic biomarkers in oral squamous cell carcinoma: current evidence and future directions. | Front Oncol | 2025 | 41426322 | PubTator, text mining | PubMed |
| TROP-2 Promotes Cell Proliferation via the AKT-Mediated PKCα Pathway and Is a Novel Target for Antibody-Drug Conjugates in Penile Carcinoma. | Oncol Res | 2025 | 41425706 | PubTator, text mining | PubMed |
| Integrated Biomimetic Platform for Enhancing the Efficient Capture and Visual Identification of Circulating Tumor Cells. | Anal Chem | 2025 | 41384307 | PubTator, text mining | PubMed |
| Tracking CTC Dynamics: Trop2 and EpCAM in Metastatic Breast Cancer Progression. | Cancers (Basel) | 2025 | 41375085 | PubTator, text mining | PubMed |
| Advances in Targeted Therapy for Non-Small-Cell Lung Cancer: Current Progress and Future Directions. | Int J Mol Sci | 2025 | 41373672 | PubTator, text mining | PubMed |
| Convergence of mRNA technology and chimeric antigen receptor therapy: targeted technology optimizing targeted therapy. | J Transl Med | 2025 | 41366793 | PubTator, text mining | PubMed |
| Near-infrared photoimmunotherapy for effective elimination of ovarian cancer cells by inducing immunogenic cell death. | Mol Ther Oncol | 2025 | 41362788 | PubTator, text mining | PubMed |
| Interrogating the Involvement of Autophagy, Senescence, and the Immune System in the Actions of Sacituzumab Govitecan as an Anticancer Agent. | Front Biosci (Landmark Ed) | 2025 | 41351402 | PubTator, text mining | PubMed |
Comment on "Baseline hemoglobin and neutrophil-to-lymphocyte ratio as prognostic biomarkers in patients with metastatic triple-negative breast cancer treated with sacituzumab govitecan in second line and beyond: a real-world analysis". | Breast Cancer Res Treat | 2025 | 41348236 | PubTator, text mining | PubMed |
| Exosomal TACSTD2 promotes invasion, metastasis and glycolysis in ovarian cancer. | Discov Oncol | 2025 | 41331197 | PubTator, text mining | PubMed |
| A TROP2-targeting ADC synergizes with oxidative phosphorylation inhibitor to enhance apoptosis in ESCC by suppressing the PI3K-AKT-mTOR signaling pathway. | Cell Death Dis | 2025 | 41326355 | PubTator, text mining | PubMed |
| In silico design of a multi-epitope vaccine against the triple negative breast cancer. | Sci Rep | 2025 | 41309872 | PubTator, text mining | PubMed |
| Real-world insights into the prevalence and prognostic significance of trophoblast cell-surface antigen 2 and folate receptor alpha in uterine carcinosarcoma. | BMC Cancer | 2025 | 41286743 | PubTator, text mining | PubMed |
| Structure of the giant RNA polymerase ejected from coliphage N4. | Res Sq | 2025 | 41282253 | PubTator, text mining | PubMed |
| Trop2 expression, p16 expression status, and histologic subtype in carcinoma of the uterine cervix. | Pathol Oncol Res | 2025 | 41280245 | PubTator, text mining | PubMed |
| YAP1 defines an emergent, plastic population of relapsed small cell lung cancer. | bioRxiv | 2025 | 41279637 | PubTator, text mining | PubMed |
| Establishment of a new method for detection of TROP2-positive circulating tumor cells in breast cancer. | BMC Cancer | 2025 | 41272532 | PubTator, text mining | PubMed |
| Monitoring Triple-Negative Breast Cancer with a Trop2-targeted Peptide PET Probe. | Radiol Imaging Cancer | 2025 | 41269134 | PubTator, text mining | PubMed |
| Treatment-Related Adverse Events of Antibody-Drug Conjugate Monotherapy in Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis. | Thorac Cancer | 2025 | 41268683 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4070/papers?page=21